Immune Response to COVID-19 Vaccine in Immunotherapy (IO) and Non-IO Treated Cancer Patients
NCT05062525 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53
Last updated 2023-05-09
Summary
Evaluation of antibody response against SARS-CoV-2 vaccination in patients treated with IO-treatment, in comparison with antibody titers in patients treated with non-IO treatment.
Conditions
Sponsors & Collaborators
-
University Health Network, Toronto
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-09-28
- Primary Completion
- 2021-09-28
- Completion
- 2021-09-28
Countries
- Canada
Study Locations
More Related Trials
-
Antibodies Production After Covid-19 Vaccination Among Patients With Medical History of Cancer and Anti-CD-20 Treatment
NCT04779996 ·Status: UNKNOWN
-
Immunity to Infection in Healthy Participants and Participants With Cancer
NCT05787964 ·Status: ACTIVE_NOT_RECRUITING
-
Responses to COVID-19 Vaccination in Patients With Cancer
NCT04745377 ·Status: COMPLETED
-
Host Immune Response to Novel RNA COVID-19 Vaccination
NCT04784689 ·Status: COMPLETED
-
Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active Treatment
NCT05119738 ·Status: UNKNOWN
-
Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection
NCT04362865 ·Status: COMPLETED
-
SARS-CoV-2 Specific Immune Response After COVID-19 Vaccination in Cancer Patients
NCT05313074 ·Status: COMPLETED ·Phase: NA
-
COVID-19-Study of Immune Responses Following Vaccination Against SARS-CoV-2
NCT04836793 ·Status: UNKNOWN
-
Viral Specific T Cell Therapy for COVID-19 Related Pneumonia
NCT04742595 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Vaccination Against COVID-19 in Cancer
NCT04715438 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals
NCT04871165 ·Status: UNKNOWN
-
Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients
NCT05164016 ·Status: COMPLETED
-
A Study on the Immune-response to COVID-19 Vaccination in Cancer Patients - the IOSI-COVID-19-001 Study
NCT04800146 ·Status: COMPLETED
-
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
NCT04960059 ·Status: COMPLETED
-
Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals
NCT04858607 ·Status: COMPLETED
-
Immune Resistance Interrogation Study
NCT04243720 ·Status: RECRUITING
-
Dendritic Cell Based Therapy of Metastatic Breast Cancer
NCT00197925 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast Cancer
NCT03113019 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Phase 1 Study of MEDI0562 in Adult Subjects With Selected Advanced Solid Tumors
NCT02318394 ·Status: COMPLETED ·Phase: PHASE1
-
Immunosuppression and COVID-19 Boosters
NCT05415267 ·Status: RECRUITING ·Phase: PHASE3
-
COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics
NCT04871932 ·Status: RECRUITING
-
Understanding COVID-19 Vaccine Immunity in Tissue and Blood
NCT05682625 ·Status: WITHDRAWN
-
Investigating The Experiences of Patients In Immunotherapy Clinical Trials
NCT05435365 ·Status: NOT_YET_RECRUITING
-
Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy of Immunotherapies
NCT06626269 ·Status: RECRUITING ·Phase: NA
-
Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies
NCT04878822 ·Status: UNKNOWN